AzTrials
AzTrials

Umbilical HerniaSUMMERNCT04231071

Mesh Versus Suture Repair in Umbilical Hernias - A Multicenter Trial

A study testing Onlay Mesh group in people with Umbilical Hernia, run by Karolinska Institutet at 7 sites in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Umbilical hernia repair is one of the most common surgical performance in general surgery. Up to now, the use of suture repair has been the preferred technique for small umbilical hernia defects without any gold standard procedure. Mesh have been reserved to larger umbilical hernia defects. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Umbilical Hernia
What is being tested?
Onlay Mesh group
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
288 participants
Where
7 sitesSweden
Study dates
3 Feb 2020to 3 Jan 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Elective surgery of a primary umbilical hernia with a defect ≤ 2 cm that is measured clinically or with radiology.

Who cannot join

  • Incisional hernia: previous surgery in the area of the operation
  • Recurrent umbilical hernia
  • Epigastric hernia (a defect from 3 cm below the xiphoid till 3 cm above the umbilicus) [20]
  • Another operative procedure at the same time (i.e. cholecystectomy)
  • An umbilical hernia with a defect > 2 cm measured clinically, with radiology or intra-operatively
  • Multiple defects
Show all 14Show fewer
  • Pregnancy
  • Infected wounds
  • Acute operation (incarcerated hernia)
  • BMI>35
  • Ascites
  • Immunosuppression
  • Anticoagulant treatment (Warfarin, NOAK)
  • Connective tissue disease

Trial locations and contacts

7 sites in 1 country.

7 sites in 1 country

Sweden7 sites
  • Enköping Lasarett

    Enköping

  • Frölunda Hospital

    Gothenburg

  • Mora Lasarett

    Mora

  • Department of Surgery at Södertälje Hospital

    Södertälje, 151 39

  • Danderyds Hospital

    Stockholm

  • Norrtälje Hospital

    Stockholm

  • Sophiahemmet/GHP

    Stockholm

Other trials in Sweden

About this study

Official title: Randomized Double-blind Controlled Multicenter Trial Comparing Suture and Mesh Repair in Small Umbilical Hernias in Adults

Umbilical hernia repair is one of the most common surgical performance in general surgery. Up to now, the use of suture repair has been the preferred technique for small umbilical hernia defects without any gold standard procedure. Mesh have been reserved to larger umbilical hernia defects. However, there is an increasing evidence that mesh reinforcement could be advantageous to lower the high recurrence rates also in smaller umbilical hernias. A remained important question is in what anatomical position the mesh should be placed. The investigators hypothesize that the use of an onlay mesh in small umbilical hernia defects can reduces recurrence rates without increasing postoperative complications compared to a suture repair.

Read the detailed description

The trial is a prospective multicenter randomized clinical trial comparing onlay mesh to suture repair. Two hundred and eighty-eight patients with a primary elective umbilical hernia below and equal to 2 cm from seven Swedish participating surgical centers will be enrolled. Randomization will be performed intraoperatively following the measurement of the defect (with stratification for centra and for the defect size) to either closing the small umbilical defect with a simple primary suture repair or closing the defect with a simple primary suture repair with an attached small flat lightweight polypropylene only mesh on the aponeurosis. Trial participants, investigators and follow-up clinical surgeons will be blinded for the assigned allocation. The primary endpoint will be recurrence at 1 and 3 years. Secondary endpoint will be surgical site postoperative complications at 30 days and pain 1 year after surgery. As follows, participants will be visiting the outpatient clinical at 30 d, 1 year and 3 year after surgery.

All analyses will be performed according to the intention to treat principle and as specified in the analyses plan of the study protocol.

There is no randomized clinical trial today comparing recurrence rates between an onlay mesh repair and a suture repair for small umbilical hernia defects. The trial design allows a good detection of differences in recurrence with the large sample size and the adequate follow-up. Surgeons are becoming more aware of the mesh's advantage even for the small defects, but are reluctant to use a mesh due to anatomical positions with a large dissection and an increased risk of complications. A small onlay mesh could be an easy and safe method of choice for small umbilical hernia defects to avoid increased recurrence rates. Guidelines for small umbilical hernia repairs have stressed out the need for reliable data for treatment recommendations. The investigators can expect that the trial will have a direct implication on small umbilical hernia repair standards.

The clinical study protocol has underwent full external peer review as part of the funding process with Research funding from SLL (Stockholms läns landsting) Karolinska Institutet. Approval of the protocol by the Swedish Ethical Review Authority was obtained at December 2018 and January 2020.

Being tested
Onlay Mesh group
Keywords
Small umbilical hernias, mesh repair, suture repair, recurrence
Medical subject headings
Hernia, Umbilical, Recurrence

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Onlay Mesh groupDevice

    Primary suture repair with a small only mesh on the closed defect

Study groups in NCT04231071
Study groupRoleWhat they receive
Sutured groupActive comparatorControlled group: Primary suture repair of the small umbilical hernia defect
Receives: Device: Onlay Mesh group
Onlay Mesh groupExperimentalIntervention group: Primary suture repair of the small umbilical hernia defects + a small Onlay mesh on the closed defect.
Receives: Device: Onlay Mesh group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hernia recurrence rate

    To evaluate whether an onlay mesh in the repair of primary small umbilical hernias ≤ 2 cm reduces recurrence rate compared to suture repair 3 year after surgery

    Measured: 3 year

  2. Hernia recurrence rate

    To evaluate whether an onlay mesh in the repair of primary small umbilical hernias ≤ 2 cm reduces recurrence rate compared to suture repair 1 year after surgery.

    Measured: 1 year

Secondary outcomes (2)
  1. Difference in Surgical postoperative complication rate

    To compare the two groups of patients with regard to surgical postoperative complications (seroma, hematoma, infection) 30 days after surgery.

    Measured: 30 days

  2. Difference in Pain rate after surgery assessed by VHPQ

    To compare the two groups of patients with regard to postoperative pain rate 1 year after surgery assessed by VHPQ (Ventral Hernia Pain Questionnaire)

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2020
  2. Study start3 Feb 2020
  3. Primary completion3 Jan 2024
  4. Study completion3 Jan 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
288 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04231071
Sponsor's protocol ID
SUMMER2020
Other IDs
SUMMER Trial
Acronym
SUMMER
Status last verified
Oct 2023
First submitted
10 Jan 2020
Last updated
6 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bergstrom M, Widhe B, Granasen G, Lof Granstrom A, Ohlsson J, Schult S, Dahlstrand U, Osterberg J, Loogna P, Bringman S, Melkemichel M. Onlay mesh versus suture repair for smaller umbilical hernias in adults-early results from SUMMER trial: randomized clinical trial. BJS Open. 2024 Dec 30;9(1):zrae173. doi: 10.1093/bjsopen/zrae173.

    PubMed 40037347
  • Melkemichel M, Bringman S, Granasen G, Widhe B. SUMMER Trial: mesh versus suture repair in small umbilical hernias in adults-a study protocol for a prospective randomized double-blind multicenter clinical trial. Trials. 2021 Jun 22;22(1):411. doi: 10.1186/s13063-021-05366-7.

    PubMed 34158088

Questions about this trial

What is this clinical trial studying?

A study testing Onlay Mesh group in people with Umbilical Hernia, run by Karolinska Institutet at 7 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hernia recurrence rate (time frame: 3 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04231071, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in